...
首页> 外文期刊>Journal of receptor and signal transduction research >The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells
【24h】

The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β-cells

机译:FoxO / Bcl-6 / cyclin D2通路介导新陈代谢和生长因子刺激Min6胰腺β细胞的增殖

获取原文
获取原文并翻译 | 示例
           

摘要

Lack of nutrients and growth factors activates FoxO transcription factors in pancreatic β-cells, whereas PI3K/Akt-dependent inactivation of FoxO favors proliferation. To address the link between FoxO and cell cycle control, we deprived Min6 cells of serum and glucose which activated FoxO and inhibited prolifera-tion. Concomitantly, expression of the transcriptional repressor Bcl-6 was stimulated, whereas cyclin D2 was lowered. Gain of function approaches indicated that FoxO activation was sufficient to activate bcl-6 transcription, while Bcl-6 repressed cyclin D2 transcription and proliferation. Thus, in pancreatic β-cells, the FoxO/Bcl6/cyclin D2 pathway connects nutrient and growth factor status to cell cycle control, and may therefore be considered for its therapeutic potential in diabetes.
机译:营养物质和生长因子的缺乏会激活胰腺β细胞中的FoxO转录因子,而依赖PI3K / Akt的FoxO失活会促进增殖。为了解决FoxO与细胞周期控制之间的联系,我们剥夺了Min6细胞的血清和葡萄糖,这些血清和葡萄糖激活了FoxO并抑制了增殖。伴随地,转录阻抑物Bcl-6的表达被刺激,而细胞周期蛋白D2被降低。功能途径的获得表明,FoxO激活足以激活bcl-6转录,而Bcl-6抑制细胞周期蛋白D2转录和增殖。因此,在胰腺β细胞中,FoxO / Bcl6 /细胞周期蛋白D2途径将营养和生长因子的状态与细胞周期控制联系起来,因此可以考虑其在糖尿病中的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号